Cargando…
Lipoprotein (a), Inflammation, and Atherosclerosis
Growing evidence has shown that high levels of lipoprotein (a) (Lp(a)) and chronic inflammation may be responsible for the residual risk of cardiovascular events in patients managed with an optimal evidence-based approach. Clinical studies have demonstrated a correlation between higher Lp(a) levels...
Autores principales: | Di Fusco, Stefania Angela, Maggioni, Aldo Pietro, Scicchitano, Pietro, Zuin, Marco, D’Elia, Emilia, Colivicchi, Furio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095203/ https://www.ncbi.nlm.nih.gov/pubmed/37048611 http://dx.doi.org/10.3390/jcm12072529 |
Ejemplares similares
-
Spotlight on Italian Association of Hospital Cardiologists (ANMCO) activity in the 2–year period 2021–2023
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023) -
Electrocardiographic characteristics, anthropometric features, and cardiovascular risk factors in a large cohort of adolescents
por: Santini, Massimo, et al.
Publicado: (2018) -
The Impact of the Coronavirus Disease-2019 Pandemic and Italian Lockdown Measures on Clinical Presentation and Management of Acute Heart Failure
por: Colivicchi, Furio, et al.
Publicado: (2020) -
Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
por: Lucà, Fabiana, et al.
Publicado: (2021) -
ANMCO POSITION PAPER: Prognostic and therapeutic relevance of non-obstructive coronary atherosclerosis
por: Casolo, Giancarlo, et al.
Publicado: (2021)